JPRN-UMIN000034815已完成未知
Response-oriented sequential therapy with four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma - Response-oriented MPB/Rd sequential therapy for NDMM
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 66years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •plasma cell leukemia, cardiac amyloidosis, POEMS syndrome, grade 2-4 neuropathy, other malignancy within past 3 years, and other serious complications
研究者
相似试验
招募中
1 期
Efficacy of a sequential treatment strategy in Rheumatoid Arthritis.Rheumatoid ArthritisCTIS2022-500234-29-00niversity Hospital Montpellier220
已完成
3 期
Sequential Therapy versus Quadruple Therapy for Helicobacter pylori EradicatioIRCT20171230038142N20Esfahan University of Medical Sciences174
已完成
1 期
Sequential Therapy versus Quadruple Therapy for H.pylori Eradication in IraIRCT201103183836N1Jundishapour Ahvaz Uuniversity of Medical Science300
尚未招募
不适用
Verification of the impact on sequential therapy Of romosozumab according to the administration period of teriparatideosteoporosisJPRN-UMIN000036854Shinshu University School of Medicine Dept. of Orthopaedic Surgery90
已完成
不适用
Sequential therapy versus the best quadriple drug therapy for helicobacter pylori eradicatioDuodenal ulcerPeptic Ulcer Disease (H. Pylori eradication).IRCT138807022499N1Vice Chancellor For Research, Mazandaran University of Medical Sciences296